Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human SIRP alpha Protein (Fc Chimera 6xHis Tag) (AC1083)
Cat.#: ACPP-1083
Specifications
Despition Recombinant Human SIRP alpha Protein (Fc Chimera 6xHis Tag) for ELISA, SDS-PAGE, Flow Cytometry SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence SIRPa (Glu31-Tyr373) + hFc (Glu99-Ala330) + 6×His Tag Molecular Weight 70-98 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Human Fc Tag and 6×His Tag Applications ELISA, SDS-PAGE, Flow Cytometry Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1505 Human CRYGD Protein (AC1505) 5 µg inquiry ACPP-1649 Human EFNA5 Protein (AC1649) 2 µg inquiry ACPP-1467 Human SCN3B Protein (AC1467) 2 µg inquiry ACPP-1141 Recombinant Human Prion Protein PrP Protein (Fc Tag) (AC1141) 50 µg inquiry ACPP-1442 Human TBCB Protein (AC1442) 5 µg inquiry ACPP-1325 Synaptotagmin 1 Blocking Peptide (AC1325) 250 µg inquiry ACPP-1534 Human RLN3 Protein (AC1534) 5 µg inquiry ACPP-1052 Recombinant Human PGRPS Protein (Fc Tag) (AC1052) 50 µg inquiry ACPP-1541 Human OTOR Protein (AC1541) 5 µg inquiry ACPP-1567 Human EFNB2 Protein (AC1567) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket